Head-to-head · Cost-Efficiency Index
FitRx vs Boston Medical Group
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
FitRx
Cost-first shoppers who want insured patients trying to unlock brand-name GLP-1 access below list price.
Visit FitRxBoston Medical Group
Cost-first shoppers who want a clinician-run 12-week program and can accept a price quoted as a range rather than a rate.
Visit Boston Medical GroupThe verdict
FitRx and Boston Medical Group tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with FitRx (ranked #265, a hair above #269) — Cost-first shoppers who want insured patients trying to unlock brand-name GLP-1 access below list price. But Boston Medical Group is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs FitRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | FitRx | Boston Medical Group |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | Not disclosed | $199/mo (starting strength, rising with dose, compounded) |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | $2,388 |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | All 50 states | 7 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #265 | #269 |
FitRx
59/100Where the value is
- All 50 states + DC coverage
- LegitScript certified
- All four major brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) available if insurance coordination succeeds
The tradeoffs
- The headline '$25/month' price is not a standing self-pay rate — it's an insurance-dependent outcome the site itself hedges with 'roughly', so most uninsured shoppers will pay $151/mo instead
- No compounded tirzepatide offered at all — semaglutide-only on the compounded side
Regulatory note: the FDA issued a warning letter to FitRX, LLC dba FitRx in February 2026. We still list and link to FitRx; you should know the letter is on the public record before you decide.
Boston Medical Group
59/100Where the value is
- An established medical group with a defined 12-week program rather than an open-ended subscription
- The price range and the 12-week total are both published, once you reach the costs page
- Semaglutide is prescribed and dispensed under a compounded pathway with clinician oversight
The tradeoffs
- The published rate is a range by dose strength, $199 to $299, so the figure quoted is the floor rather than what a titrated patient pays
- The 12-week program totals $699 including a telemedicine platform fee that is never itemised — about $233/mo all-in, not $199
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.